Aimovig is a once-monthly self-injection for the prevention of migraines. By taking Aimovig, you can reduce the number of migraine-free days each month, allowing you to reclaim your time with friends and family. Aimovig (which uses the medical name Erenumab) is a chemical that blocks calcitonin gene-related peptide (CGRP) receptors. The monoclonal antibody has been developed in a lab from immune system cells to help support healing and injury prevention.

Your body has both CGRP and CGRP receptors. Doctors have found that CGRP attaches to a receptor and triggers migraine attacks. Aimovig works to block these receptors so the CGRP cannot attach to them. As a result, you may experience fewer migraines throughout the month.

In some patients, Aimovig cut the number of average migraine days in half each month. Across a three-month study, people who took Aimovig experienced six to seven fewer chronic migraine days each month compared to less than four fewer each month for the placebo group. Patients also noticed three to four fewer episodic migraines compared to less than two fewer for the placebo group.

Aimovig is recommended for patients who cannot reduce their number of monthly migraines through other drugs or who can’t take another medication because of drug interactions. Aimovig may not be right for everyone, but this is a promising step toward long-term migraine prevention instead of reaction-based treatment.


If you have a busy day ahead of you, don’t let a painful migraine stand in your way of finishing important tasks. Nurtec ODT can reduce or get rid of your migraines altogether approximately an hour after taking it. This pain relief can even last for up to 48 hours. At Nurx™, we love how quickly this pill kicks in to give you the immediate and long-lasting pain relief you deserve.

One pill contains 75 milligrams and quickly dissolves in your mouth, so no water is needed to help swallow it. Nurtec ODT is known as an acute treatment, meaning it’ll stop your migraines after they begin. Because of this, Nurtec doesn’t prevent migraines from occurring. Instead, take one pill as soon as you feel the migraine start. Soon enough, you’ll feel much better and be ready to continue with your day.


Ubrelvy the brand name of the prescription drug Ubrogepant. Ubrelvy is used to treat the symptoms of a migraine attack in adults and is a Calcitonin Gene-Related Peptide receptor inhibitor (CGRP). It is the first and only oral CGRP approved by the United States Food and Drug Administration to treat migraine attacks. It comes in tablet form and can treat migraines with or without aura, which are sensory phenomena that can cause visual sensitivity, disturbances, and discomfort.

Ubrelvy is the first oral acute migraine treatment within the CGRP class of migraine medications. Previously, patients who suffered from severe migraines had injectable options. Patients who have used Ubrelvy have reported success in alleviating some or all of their migraine symptoms.


If you regularly suffer from migraines, consider a prescription for Emgality to help lessen symptoms and relieve the pain and sensitivity that comes from these attacks. Emgality is an FDA-approved injection you take once per month for the prevention of and relief from migraines and cluster headaches. Emgality works by targeting what’s called the calcitonin gene-related peptide that is responsible for the pain and inflammation associated with migraines.

The medicine blocks this protein to reduce and eliminate migraine attacks by behaving like the antibodies (monoclonal antibodies) the body produces to fight off infection or pathogens. Emgality works as a monoclonal antibody to attach to the CGRP protein and eliminate your migraines.

Back to top